News
(Alliance News) - Computacenter PLC on Monday said softer trading in Germany and France and increased investment means first half adjusted profit would be only slightly ahead of a year ago. In ...
(Alliance News) - AstraZeneca PLC on Monday said the US Food & Drug Administration has granted priority review for its immunotherapy drug Imfinzi for some cancer forms.
(Alliance News) - Keir Starmer is expected to raise the prospect of reviving ceasefire talks between Israel and Hamas and the future of tariffs on British steel as he meets Donald Trump in Scotland.
GSK will pay USD500 million in upfront fees across the agreements. The total value of success-based development, regulatory and commercial milestone payments to Hengrui Pharma is around USD12 billion, ...
(Alliance News) - Valterra Platinum Ltd on Monday reported a drop in interim profit due in part to one-off costs of its demerger from parent Anglo American PLC, but also due sharply lower production.
(Alliance News) - GSK announced a partnership with China's Hengrui, Cranswick said it expects results in line with market expectations, while STV warned of an annual outcome below consensus. Here is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results